Table 6.
Total costs of each prophylaxis strategy in the eTHR and eTKR models.
| Population and strategy | Total costs of pharmacological prophylaxis (I) | Total costs of mechanical prophylaxis (II) | Total intervention cost (I+II) |
|---|---|---|---|
| THR | |||
| LMWH (std,std) + AES | £138 | £31 | £169 |
| LMWH (std,extd)+ AES | £387 | £31 | £419 |
| Fondaparinux+ AES | £83 | £31 | £115 |
| Foot pump + AES | £0 | £91 | £91 |
| IPCD | £0 | £42 | £42 |
| AES (above knee) | £0 | £34 | £34 |
| Foot pump | £0 | £59 | £59 |
| AES | £0 | £31 | £31 |
| LMWH (std,std) | £138 | £0 | £138 |
| LMWH (std,extd) | £387 | £0 | £387 |
| Aspirin (std duration) | £0.2 | £0 | £0.2 |
| LMWH (std, std) + Aspirin (extd duration) | £115 | £0 | £115 |
| Dabigatran | £80 | £0 | £80 |
| Apixaban | £59 | £0 | £59 |
| Rivaroxaban | £74 | £0 | £74 |
| No prophylaxis | £0 | £0 | £0 |
| TKR | |||
| LMWH (std,std) + AES | £111 | £31 | £142 |
| Fondaparinux+ AES | £97 | £31 | £128 |
| Foot pump + AES | £0 | £91 | £91 |
| IPCD | £0 | £42 | £42 |
| Foot pump | £0 | £59 | £59 |
| AES | £0 | £31 | £31 |
| LMWH (std,std) | £111 | £0 | £111 |
| LMWH (std,extd) | £355 | £0 | £355 |
| Aspirin | £0.5 | £0 | £0.5 |
| Dabigatran | £34 | £0 | £34 |
| Apixaban | £23 | £0 | £23 |
| Rivaroxaban | £25 | £0 | £25 |
| No prophylaxis | £0 | £0 | £0 |
AES, anti-embolism stockings; eTKR, elective total knee replacement; eTHR, elective total hip replacement; extd, extended; IPCD.